EUVIMEDSkopri EUVIMED
Crossref

rasa1 -related arteriovenous malformation is driven by aberrant venous signalling

Jasper Greysson-Wong iD, Rachael Rode, Jae-Ryeon Ryu iD, Jo Li Chan, Paniz Davari, Kristina D Rinker iD, Sarah J Childs iD

Development · 2023

DOI: 10.1242/dev.201820 ↗

At a glance

Journal article in Development, 2023. Written by Jasper Greysson-Wong and 6 co-authors. Institution: Alberta Children's Hospital Research Institute, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada. Major MEDLINE topics: Arteriovenous Malformations, Zebrafish Proteins. Cited 16 times so far (Crossref); 65 references. Funded by: CIHR, Cumming School of Medicine, University of Calgary, Canadian Institutes of Health Research.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Arteriovenous malformations (AVMs) develop where abnormal endothelial signalling allows direct connections between arteries and veins. Mutations in RASA1, a Ras GTPase activating protein, lead to AVMs in humans and, as we show, in zebrafish rasa1 mutants. rasa1 mutants develop cavernous AVMs that subsume part of the dorsal aorta and multiple veins in the caudal venous plexus (CVP) – a venous vascular bed. The AVMs progressively enlarge and fill with slow-flowing blood. We show that the AVM results in both higher minimum and maximum flow velocities, resulting in increased pulsatility in the aorta and decreased pulsatility in the vein. These hemodynamic changes correlate with reduced expression of the flow-responsive transcription factor klf2a. Remodelling of the CVP is impaired with an excess of intraluminal pillars, which is a sign of incomplete intussusceptive angiogenesis. Mechanistically, we show that the AVM arises from ectopic activation of MEK/ERK in the vein of rasa1 mutants, and that cell size is also increased in the vein. Blocking MEK/ERK signalling prevents AVM initiation in mutants. Alterations in venous MEK/ERK therefore drive the initiation of rasa1 AVMs.

Subjects

MeSH terms (MEDLINE)

Arteriovenous MalformationsZebrafish ProteinsAnimalsHumansGTPase-Activating ProteinsMitogen-Activated Protein Kinase Kinasesp120 GTPase Activating ProteinVeinsZebrafish

Author keywords

Arteriovenous malformationBlood vesselMAPKRASA1

Substances

GTPase-Activating ProteinsMitogen-Activated Protein Kinase Kinasesp120 GTPase Activating ProteinRASA1 protein, humanrasa1a protein, zebrafishZebrafish Proteins

Authors and institutions

  • Alberta Children's Hospital Research Institute, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
  • Department of Biochemistry and Molecular Biology, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
  • Department of Chemical and Petroleum Engineering, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.

ORCID profiles: Jasper Greysson-Wong, Jae-Ryeon Ryu, Kristina D Rinker, Sarah J Childs

Funding

  • CIHR
  • Cumming School of Medicine, University of Calgary
  • Canadian Institutes of Health Research
  • Heart and Stroke Foundation of Canada
  • Natural Sciences and Engineering Research Council of Canada

Cite

APA

Greysson-Wong, J., Rode, R., Ryu, J. R., Chan, J. L., Davari, P., Rinker, K. D., & Childs, S. J. (2023). rasa1 -related arteriovenous malformation is driven by aberrant venous signalling. Development. https://doi.org/10.1242/dev.201820

Vancouver

Greysson-Wong J, Rode R, Ryu JR, Chan JL, Davari P, Rinker KD, et al. rasa1 -related arteriovenous malformation is driven by aberrant venous signalling. Development. 2023. doi:10.1242/dev.201820

BibTeX
@article{GreyssonWong2023,
  author = {Greysson-Wong, Jasper and Rode, Rachael and Ryu, Jae-Ryeon and Chan, Jo Li and Davari, Paniz and Rinker, Kristina D and Childs, Sarah J},
  title = {rasa1 -related arteriovenous malformation is driven by aberrant venous signalling},
  journal = {Development},
  year = {2023},
  doi = {10.1242/dev.201820}
}
Start for free →